513 related articles for article (PubMed ID: 12791810)
1. Initial human PET imaging studies with the dopamine transporter ligand 18F-FECNT.
Davis MR; Votaw JR; Bremner JD; Byas-Smith MG; Faber TL; Voll RJ; Hoffman JM; Grafton ST; Kilts CD; Goodman MM
J Nucl Med; 2003 Jun; 44(6):855-61. PubMed ID: 12791810
[TBL] [Abstract][Full Text] [Related]
2. 18F-labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters.
Goodman MM; Kilts CD; Keil R; Shi B; Martarello L; Xing D; Votaw J; Ely TD; Lambert P; Owens MJ; Camp VM; Malveaux E; Hoffman JM
Nucl Med Biol; 2000 Jan; 27(1):1-12. PubMed ID: 10755640
[TBL] [Abstract][Full Text] [Related]
3. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
[TBL] [Abstract][Full Text] [Related]
4. Rapid detection of Parkinson's disease by SPECT with altropane: a selective ligand for dopamine transporters.
Fischman AJ; Bonab AA; Babich JW; Palmer EP; Alpert NM; Elmaleh DR; Callahan RJ; Barrow SA; Graham W; Meltzer PC; Hanson RN; Madras BK
Synapse; 1998 Jun; 29(2):128-41. PubMed ID: 9593103
[TBL] [Abstract][Full Text] [Related]
5. Potential of [(18)F]beta-CFT-FE (2beta-carbomethoxy-3beta-(4-fluorophenyl)-8-(2-[(18)F]fluoroethyl)nortropane) as a dopamine transporter ligand: A PET study in the conscious monkey brain.
Harada N; Ohba H; Fukumoto D; Kakiuchi T; Tsukada H
Synapse; 2004 Oct; 54(1):37-45. PubMed ID: 15300883
[TBL] [Abstract][Full Text] [Related]
6. PET imaging of the dopamine transporter with 18F-FECNT: a polar radiometabolite confounds brain radioligand measurements.
Zoghbi SS; Shetty HU; Ichise M; Fujita M; Imaizumi M; Liow JS; Shah J; Musachio JL; Pike VW; Innis RB
J Nucl Med; 2006 Mar; 47(3):520-7. PubMed ID: 16513622
[TBL] [Abstract][Full Text] [Related]
7. Progression in Parkinson's disease: a positron emission tomography study with a dopamine transporter ligand [18F]CFT.
Nurmi E; Ruottinen HM; Kaasinen V; Bergman J; Haaparanta M; Solin O; Rinne JO
Ann Neurol; 2000 Jun; 47(6):804-8. PubMed ID: 10852547
[TBL] [Abstract][Full Text] [Related]
8. Reproducibility and effect of levodopa on dopamine transporter function measurements: a [18F]CFT PET study.
Nurmi E; Bergman J; Eskola O; Solin O; Hinkka SM; Sonninen P; Rinne JO
J Cereb Blood Flow Metab; 2000 Nov; 20(11):1604-9. PubMed ID: 11083235
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and Biological Evaluation of [
Cao S; Tang J; Liu C; Fang Y; Ji L; Xu Y; Chen Z
Mol Imaging Biol; 2021 Oct; 23(5):733-744. PubMed ID: 33851345
[TBL] [Abstract][Full Text] [Related]
10. Dopamine transporter imaging with fluorine-18-FPCIT and PET.
Kazumata K; Dhawan V; Chaly T; Antonini A; Margouleff C; Belakhlef A; Neumeyer J; Eidelberg D
J Nucl Med; 1998 Sep; 39(9):1521-30. PubMed ID: 9744335
[TBL] [Abstract][Full Text] [Related]
11. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
Fazio P; Svenningsson P; Forsberg A; Jönsson EG; Amini N; Nakao R; Nag S; Halldin C; Farde L; Varrone A
J Nucl Med; 2015 May; 56(5):714-20. PubMed ID: 25791993
[TBL] [Abstract][Full Text] [Related]
12. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biodistribution, and primate imaging of fluorine-18 labeled 2beta-carbo-1'-fluoro-2-propoxy-3beta-(4-chlorophenyl)tr opanes. Ligands for the imaging of dopamine transporters by positron emission tomography.
Xing D; Chen P; Keil R; Kilts CD; Shi B; Camp VM; Malveaux G; Ely T; Owens MJ; Votaw J; Davis M; Hoffman JM; BaKay RA; Subramanian T; Watts RL; Goodman MM
J Med Chem; 2000 Feb; 43(4):639-48. PubMed ID: 10691690
[TBL] [Abstract][Full Text] [Related]
14. Quantification of dopamine transporter density with [18F]FECNT PET in healthy humans.
Nye JA; Votaw JR; Bremner JD; Davis MR; Voll RJ; Camp VM; Goodman MM
Nucl Med Biol; 2014 Mar; 41(3):217-22. PubMed ID: 24533985
[TBL] [Abstract][Full Text] [Related]
15. Fluorine-18-FPCT: a PET radiotracer for imaging dopamine transporters.
Goodman MM; Keil R; Shoup TM; Eshima D; Eshima L; Kilts C; Votaw J; Camp VM; Votaw D; Smith E; Kung MP; Malveaux E; Watts R; Huerkamp M; Wu D; Garcia E; Hoffman JM
J Nucl Med; 1997 Jan; 38(1):119-26. PubMed ID: 8998165
[TBL] [Abstract][Full Text] [Related]
16. [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.
Halldin C; Erixon-Lindroth N; Pauli S; Chou YH; Okubo Y; Karlsson P; Lundkvist C; Olsson H; Guilloteau D; Emond P; Farde L
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1220-30. PubMed ID: 12811422
[TBL] [Abstract][Full Text] [Related]
17. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
[TBL] [Abstract][Full Text] [Related]
18. [[123I]beta-CIT SPECT imaging of dopamine and serotonin transporters in Parkinson's disease and multiple system atrophy.
Berding G; Brücke T; Odin P; Brooks DJ; Kolbe H; Gielow P; Harke H; Knoop BO; Dengler R; Knapp WH
Nuklearmedizin; 2003 Feb; 42(1):31-8. PubMed ID: 12601452
[TBL] [Abstract][Full Text] [Related]
19. (18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism.
Masilamoni G; Votaw J; Howell L; Villalba RM; Goodman M; Voll RJ; Stehouwer J; Wichmann T; Smith Y
Exp Neurol; 2010 Dec; 226(2):265-73. PubMed ID: 20832405
[TBL] [Abstract][Full Text] [Related]
20. Semi-automated preparation of the dopamine transporter ligand [(18)F]FECNT for human PET imaging studies.
Voll RJ; McConathy J; Waldrep MS; Crowe RJ; Goodman MM
Appl Radiat Isot; 2005 Sep; 63(3):353-61. PubMed ID: 15985372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]